Natasha Szuber

DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions

Manuel Buscarlet, Sylvie Provost, Yassamin Feroz Zada et al. · Blood · 2017 · 379 citations · Full text

Life Sciences, Genetics, Hematology +16

Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho et al. · British Journal of Haematology · 2020 · 221 citations

Life Sciences, Genetics, Hematology +11

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber, Mythri Mudireddy, Maura Nicolosi et al. · Mayo Clinic Proceedings · 2019 · 163 citations

Medicine, Hematology, Oncology +13

Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients

Ayalew Tefferi, Maura Nicolosi, Mythri Mudireddy et al. · American Journal of Hematology · 2017 · 118 citations

Medicine, Genetics, Hematology +14

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms

Terra L. Lasho, Mythri Mudireddy, Christy M. Finke et al. · Blood Advances · 2018 · 115 citations · Full text

Medicine, Hematology, Oncology +14